Mercury Reaches 52 Billion Valuation in Latest Funding Round Signaling Resilience in Fintech Sector Park Medi World Shares May Offer 20 Upside After 90 YTD Surge on Capacity Expansion Iran Tensions Escalate After Trump Rejects Peace Counteroffer Strait of Hormuz Disruption Risks Grow Alaska Air Group Explores Integration of Boeings Virtual Airplane Technology Synopsys Faces Potential Decline in Q2 Earnings as Analysts Adjust Forecasts General Motors Unveils AllElectric Cadillac Vistiq With 300Mile Range Expanding Luxury EV Lineup AMWD Q1 2026 Earnings EPS Surges Past Estimates with 60 Beat CSV Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Signals STKS Q1 2026 Earnings WiderthanExpected Loss as EPS Misses Estimates Significantly QVCGP Q3 2025 Earnings Preferred Stock Reports Substantial Loss per Share Amid Quiet Market Reaction VersaBank VBNK Q1 2026 Earnings EPS Miss Amid Challenging Quarter Constellium SE CSTM Q1 2026 Earnings EPS Soars 128 Above Consensus Stock Rises SBC Medical Group Holdings SBC Edges Lower Amid Light Trading Key Levels in Focus Serina Therapeutics Inc SER Recovers 493 as Stock Approaches Key Resistance at 208 Entrada Therapeutics TRDA Edges Higher as Stock Tests Key Support Zone Definitive Healthcare DH Surges 593 as Stock Bounces from Key Support Pliant Therapeutics PLRX Faces Selling Pressure Testing Key Support at 115 HFCL Shares Hit Record High After Securing 135 Crore RailTel Order Stock Surges 160 in Two Months Linde Q1 2026 Earnings EPS Beats Estimates as Margin Focus Drives Slight Stock Uptick BioHarvest Sciences Inc BHST Gains 105 While Testing Key Resistance at 405 Fair Isaac FICO Rallies 171 as Stock Tests Key Resistance Levels NewHold Investment Corp III NHIC Holds Steady Near Resistance SPAC Trading in Tight Range Diamondback Energy FANG Slips 185 as Resistance Holds Support Levels in Focus Nuveen MultiMarket Income Fund JMM Holds Steady Near 578 as Trading Remains Subdued California BanCorp BCAL Edges Higher Amid Steady Trading Mister Car Wash MCW Holds Steady Near Key Support Neutral Trading Range Corbus Pharmaceuticals CRBP Slides 14 as Key Support Level Comes into Focus